Ocugen (NASDAQ: OCGN) director receives grant of 170,100 stock options at $1.22
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Ocugen, Inc. director Chandrasekhar Satishchandran received a grant of stock options covering 170,100 shares of common stock. The options have an exercise price of $1.22 per share and expire on June 11, 2036.
The award vests upon the earlier of June 11, 2027 or Ocugen’s next annual meeting of stockholders, subject to his continued service through the vesting date. After this grant, his reported derivative holdings in this award total 170,100 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Chandrasekhar Satishchandran
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 170,100 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 170,100 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 170,100 options
Exercise price: $1.22 per share
Underlying shares: 170,100 shares
+3 more
6 metrics
Option grant size
170,100 options
Stock Option (Right to Buy) granted on June 11, 2026
Exercise price
$1.22 per share
Conversion or exercise price of the stock option grant
Underlying shares
170,100 shares
Common stock underlying the granted options
Expiration date
June 11, 2036
Option expiration for this grant
Vesting date trigger
June 11, 2027 or next annual meeting
Earlier of two dates, subject to continued service
Post-grant derivative holdings
170,100 options
Total options from this award following the transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, annual meeting of stockholders
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "1.2200" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"or (b) Ocugen, Inc.'s next annual meeting of stockholders"
FAQ
What did Ocugen (OCGN) director Chandrasekhar Satishchandran report on this Form 4?
He reported receiving a grant of stock options for 170,100 shares of Ocugen common stock. These options are a compensation award and give him the right to buy shares at a fixed exercise price in the future.
How many Ocugen (OCGN) stock options were granted and at what exercise price?
The grant covers 170,100 stock options with an exercise price of $1.22 per share. This means he can purchase Ocugen common stock at $1.22 per share once the options vest and are exercisable, subject to the plan terms.
When do Chandrasekhar Satishchandran’s Ocugen (OCGN) options vest?
The options vest on the earlier of June 11, 2027 or Ocugen’s next annual meeting of stockholders. Vesting is conditioned on his continued service with the company through the applicable vesting date, according to the footnote disclosure.
What is the expiration date of the Ocugen (OCGN) stock options granted?
These stock options expire on June 11, 2036 if not exercised earlier. After that date, the right to purchase Ocugen common stock under this grant lapses, so any unexercised options would no longer be usable.